VIKING GLOBAL INVESTORS LP 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-20 6:05 pm Purchase |
2024-03-18 | 13G | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 58,651,170 15.300% |
29,544,805 (+101.51%) |
Filing |
| 2024-01-09 4:46 pm Purchase |
2024-01-05 | 13G | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 29,106,365 9.500% |
20,817,249 (+251.14%) |
Filing |
| 2023-11-22 4:15 pm Unchanged |
2023-10-04 | 13D | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% |
0 (Unchanged) |
Filing |
| 2023-10-16 4:30 pm Sale |
2023-10-04 | 13D | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% |
-34,705 (-0.42%) |
Filing |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,323,821 9.500% |
8,323,821 (New Position) |
Filing |